Buy or sell Cytogel Pharma stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Cytogel Pharma Stock

Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.

About Cytogel Pharma Stock

Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company founded in 2002 to pursue strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. Milestone-defined investment of corporate resources permits the company to enhance product value for partnering or licensing, while retaining optimal equity value for our investors. Cytogel is venture backed by Centripetal Capital Partners.

Funding History

May 2010$2.2M
March 2014$240K
January 2015$2.7M

Management

CEO

C. Dean Maglaris

Licensing and Business Development

James J. Hamsher

Chief Scientific Officer/cofounder & Director

Theodore Maione

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Cytogel Pharma or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo